Doctor profile · Federal record
Dr. MELISSA COHEN
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · NEW HYDE PARK, NY
- NPI 1316396294
- Accepts Medicare
- MIPS 84.5 / 100 · 2023
- 10 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1999 MARCUS AVE STE 102
NEW HYDE PARK, NY 110421028
(516) 467-8600
fax (929) 455-9855
Credentials & registration
- NPI registered
- June 2016 — 10 yrs on file
- Profile last updated
- August 5, 2022
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- New York #312413
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1316396294. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,188
Distinct HCPCS
9
Medicare allowed
$159,702
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 536 | 278 | $209 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 171 | 86 | $40 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 96 | 96 | $261 | |
36415 |
Insertion of needle into vein for collection of blood sample | 95 | 85 | $8 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 95 | 86 | $3 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 67 | 62 | $151 | |
83036 |
Hemoglobin a1c level | 65 | 55 | $10 | |
G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes | 52 | 40 | $63 | |
95249 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 11 | 11 | $76 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 976. This provider delivers 1.2× the peer median.Open Payments
Industry payments received
All-time total
$228
Transactions
13
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Dexcom, Inc. | 3 | $74.82 | |
| Novo Nordisk Inc | 3 | $50.08 | |
| Amneal Pharmaceuticals LLC | 2 | $29.73 | |
| Lilly USA, LLC | 2 | $26.51 | |
| Abbott Laboratories | 1 | $18.33 | |
| Amgen Inc. | 1 | $15.19 | |
| Xeris Pharmaceuticals, Inc. | 1 | $13.20 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,547
Patients
492
Total drug cost
$1,411,910
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 271 | 66 | $460,403 |
| Jardiance (Empagliflozin) | Brand | 223 | 68 | $330,150 |
| Levothyroxine Sodium | Generic | 189 | 66 | $3,630 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 142 | 62 | $1,392 |
| Synthroid (Levothyroxine Sodium) | Brand | 95 | 32 | $8,453 |
| Trulicity (Dulaglutide) | Brand | 93 | 22 | $154,383 |
| Mounjaro (Tirzepatide) | Brand | 83 | 22 | $102,940 |
| Synjardy Xr (Empagliflozin/Metformin Hcl) | Brand | 82 | 21 | $101,815 |
| Rybelsus (Semaglutide) | Brand | 70 | 21 | $135,840 |
| Metformin Hcl | Generic | 67 | 28 | $629 |